Repaglinide NEW
| Price | $54 | $79 |
| Package | 50mg | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Repaglinide | CAS No.: 135062-02-1 |
| Purity: 99.96% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Repaglinide |
| Description | Repaglinide (AG-EE 623ZW) is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury. |
| In vitro | Repaglinide binds to NCS proteins in a calcium-dependent manner, but does not bind to CAM or S100 proteins.Repaglinide tightly binds to CCaMK and PpCaMK in a calcium-dependent manner, antagonizing the regulatory function of the structural domains, with IC 50 values of 55 mM and 4 mM for the CCaMK and PpCaMK domains.Repaglinide binds to CCaMK and PpCaMK domains with low affinity (K(D) = 59 nM) to bind SUR1 alone, but binds SUR1 with high affinity to co-express with Kir6.2, increasing it approximately 150-fold.Repaglinide antagonizes the inhibitory effect of restoring protein in the retinal kinase assay, with an IC50 value of 400 mM.Repaglinide also antagonizes the inhibitory effect of restoring protein in the retinal kinase assay, with an IC50 value of 400 mM. |
| In vivo | Repaglinide binds to NCS proteins in a calcium-dependent manner, but does not bind to CAM or S100 proteins.Repaglinide tightly binds to CCaMK and PpCaMK in a calcium-dependent manner, antagonizing the regulatory function of the structural domains, with IC 50 values of 55 mM and 4 mM for the CCaMK and PpCaMK domains.Repaglinide binds to CCaMK and PpCaMK domains with low affinity (K(D) = 59 nM) to bind SUR1 alone, but binds SUR1 with high affinity to co-express with Kir6.2, increasing it approximately 150-fold.Repaglinide antagonizes the inhibitory effect of restoring protein in the retinal kinase assay, with an IC50 value of 400 mM.Repaglinide also antagonizes the inhibitory effect of restoring protein in the retinal kinase assay, with an IC50 value of 400 mM. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Corn oil : 10 mg/mL (22.1 mM), Solution. Ethanol : 84 mg/mL (185.6 mM), Sonication is recommended. DMSO : 250 mg/mL (552.38 mM), Sonication is recommended. 10% DMSO+90% Saline : < 10 mg/mL (22.1 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. H2O : < 1 mg/mL (insoluble or slightly soluble) 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (22.1 mM), Suspension. 10% DMSO+90% (20% SBE-β-CD in Saline) : < 10 mg/mL (22.1 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. |
| Keywords | type-2 | secretagogue | Repaglinide | PPARγ | PotassiumChannel | Potassium Channel | mellitus. | insulin | Inhibitor | inhibit | diabetes | CMBA | carbamoylmethyl | benzoic | acid |
| Inhibitors Related | Rosiglitazone | Uridine 5'-monophosphate disodium salt | Daidzein | 1,8-Cineole | Tetraethylammonium bromide | Magnesium acetate tetrahydrate | Maltitol | Ursodeoxycholic acid | Chenodeoxycholic acid | 2,3-Butanediol | NPC 15199 | Cloxiquine |
| Related Compound Libraries | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Ion Channel Targeted Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $79.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-06-01 | |
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | ||
| $150.00 |
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-12-25 | ||
|
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-10-11 | ||
|
HangZhou RunYan Pharma Technology Co.,LTD.
|
2024-09-12 | |||
|
VIP3Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-04-12 | ||
| $8.00 |
VIP3Y
|
Henan Fengda Chemical Co., Ltd
|
2024-03-29 | |
| $35.00 |
Sigma Audley
|
2024-03-14 | ||
| $200.00 |
Henan Bao Enluo International TradeCo.，LTD
|
2023-07-26 | ||
|
Hefei TianRui Pharmaceutical Chemical Co., Ltd.
|
2023-04-17 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY